A randomized open comparison of long-acting injectable risperidone and treatment as usual for prevention of relapse, rehospitalization, and urgent care referral in community-treated patients with rapid cycling bipolar disorder.
Phase of Trial: Phase III
Latest Information Update: 27 Dec 2011
At a glance
- Drugs Risperidone (Primary)
- Indications Bipolar disorders
- Focus Therapeutic Use
- 27 Dec 2011 New trial record
- 01 Nov 2011 Results published in the Clinical Neuropharmacology.